# SODIUM ACETATE ANHYDROUS

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid2027044
Categories: beauty, cleaning, food, industrial, pharma
Functions: Anti-static agent, Degradant/impurity, Deodorizer, Flame retardant, Flavouring and nutrient, Fragrance, Pharmaceutical, Pigment, Surfactant (surface active agent), metal treatment, pH regulating agent, rubber production
Identifier: DTXSID2027044

> SODIUM ACETATE ANHYDROUS is used as anti-static agent / degradant/impurity. EPA CPDat observed this chemical in 621 composition records across product categories including Laboratory supplies, Food and drug, Specialty occupational products. Assessed from 18 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 621 composition records across product categories including Laboratory supplies, Food and drug, Specialty occupational products.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 621 composition records across product categories including Laboratory supplies, Food and drug, Specialty occupational products. EPA CPDat classifies this chemical for functional uses including pH regulating agent, Deodorizer, Degradant/impurity.
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 0.47 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 127 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 150 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.09 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 177 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: EMULSION; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.03 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Potency: 177 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SYRUP; Potency: 4.1 mg/1ml
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 0.16 %w/v
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: SOLUTION; Potency: NA
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: NA
- US: marketed drug occurrence — FDA NDC lists this ingredient in 15 active drug products and 15 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._